|
|
|
市場調査レポート
幹細胞研究の新たな機会に対する投資
Capitalizing on New Opportunities for Stem Cell Products
|
Abstract
Overview
As a result of the March 9, 2009 reversal of the 2001 restrictions on federal
funding of human embryonic stem cell research, suppliers of stem cell related
products are in need of a fast, accurate assessment of new opportunities in
the stem cell products market. Additionally, given that practical stem
cell-based therapies can take years to develop, suppliers would benefit from a
clear understanding of the wide range of products that support basic stem cell
research already in progress. Capitalizing on New Opportunities for Stem Cell
Products, BioInformatics LLC' s latest report, will enable suppliers to respond
quickly to a market disrupted by an Executive Order, and to gain a better
understanding of how today' s stem cell products market is driven by long-term
stem cell research requirements. In Capitalizing on New Opportunities for Stem
Cell Products, we surveyed close to 500 scientists from around the world about
their current- and planned- areas of research, usage of stem cell products and
preferred suppliers. This report will help you to determine areas poised for
growth (i.e., media, sera, supplements and cell lines) in the stem cell
research products market, identify potential key competitors (including
percentage of products purchased from each major supplier), and plan long-term
strategy to secure your leading position in this expanding market. For tactical planning purposes, the report includes detailed market share estimates across major stem cell product categories by market
segment, geographic region and top suppliers. Combined with data on
scientists' stem cell research budgets and expected changes in spending
through 2011, suppliers can use this information to anticipate areas of growth
and product saturation.
This analysis also provides suppliers with critical insight into optimizing
product offerings based upon scientists' level of satisfaction with stem cell
culture products and the level of interest in developing integrated stem cell
product lines and services. The scientists surveyed share their opinions on
what new product/technologies would be most beneficial to their research.
Additionally, the report reveals what channels stem cell scientists use to
access information relevant to their research, which in turn can be used by
suppliers to more effectively target their products and services. The March
2009 policy change could have major implications for life science suppliers as
academic scientists consider conducting research on previously unavailable
embryonic stem cell lines. While the excitement about embryonic stem cell
research is on the rise, including in the pharmaceutical and biotech industry,
suppliers need actionable information about scientists' plans to pursue
research using all types of cell lines in a global market. This report
provides insights into the origins and sources of stem cells currently used in
the lab (adult, embryonic and induced pluripotent) and those likely to be used
over the next several years- in addition to differentiated cell types and
associated diseases under investigation- allowing suppliers to anticipate the
types of stem cell culture products scientists will need to purchase.
Moreover, this report includes a supplemental section about scientists who
plan to conduct stem cell research in the near future to help companies better
anticipate the stem cell product needs of new customers.
Capitalizing on New Opportunities for Stem Cell Products provides a roadmap
for stem cell product suppliers to help navigate a landscape that is poised
for change- and growth. This analysis was designed to guide suppliers in
redirecting resources to new areas and markets, and to help refine current
offerings by making them more responsive to scientists who are already engaged
in stem cell research.
Report Objectives
- Identify new/expanding stem cell research opportunities as a result of the
ban on federal funding for research on human embryonic stem cells being lifted
- Estimate market share for stem cell research products
- Project growth of stem cell research products by market segment and
geographic region
- Learn types and species of stem cells scientists intend to use
- Determine level of satisfaction with stem cell media and unmet needs with
respect to stem cell products and cell lines
- Uncover interest in integrated stem cell workflow products and services
About BioInformatics, LLC
Since our inception in 1994, BioInformatics has provided critical market
intelligence to leading companies serving the life science, medical device and
pharmaceutical industries. We support clients across the entire market
spectrum - from scientific research to diagnostics and therapeutics -
providing high-level management with market insights from gene to drug.
Our multi-disciplinary team of scientific experts and business analysts
creates value for our clients by combining extensive industry knowledge and
experience. We offer a variety of products and services that enable executives
to see themselves, their market and their competitors through the eyes of the
most important information source of all - customers. We can precisely meet
the needs of our clients through the most appropriate mix of research
methodologies, including:
- Online Surveys
- Online Focus Groups
- Mail Surveys
- Telephone Interviews
Table of Contents
Section 1. Analysis
Market Size and Share and Market Growth Potential
- Estimated market share for stem cell research products by market segment
and geographic region
- Estimated market share of top suppliers by stem cell research product
category (i.e., media, sera, supplements, and cells)
- Projected growth of stem cell research products market by market segment
and geographic region
- Anticipated stem cell research budgets for 2009 by market segment and
geographic region
- Expected change in spending on stem cell products and cell lines over the
next two to three years (through 2011)
Frequently Asked Questions (related to):
- Products needed to support scientists' current stem cell research
- Cell types and disease that are/will be the focus of stem cell research
- Use of embryonic versus induced pluripotent cells for specific applications
- Unmet product needs and product differentiation strategies
- New product and/or service development opportunities
- Best channels by which to communicate with and market to stem cell
researchers
Section 2. Methodology & Demographics
- Objectives
- Questionnaire design
- Survey population
Section 3. Presentation of the Survey Data: Respondents Conducting Stem Cell Research
Research Overview and Applications
- Length of time conducting research
- Goals of stem cell research
- Features of stem cells studied
- Source, type, and number of different stem cell lines used in 2008
- Source, type, and number of different stem cell lines expected to be used
in 2009
- Source and type of stem cell lines plan to use two to three years from now
(2010 and 2011)
- Impact on research of lifting US restrictions on federal funding of
embryonic stem cells
- Differentiated cell types that were/are/will be the focus of stem cell
research for 2008, 2009, and two to three years from now (2010 and 2011)
- Diseases that are the focus of stem cell research by type of stem cell
- Top scientific journals respondents rate as most critical to their stem
cell research
- Critical stem cell conferences
Stem Cell Culture Products: Top Suppliers and Budgets
- Suppliers from whom respondents purchase stem cell culture products
- Percent of stem cell culture product purchases made from leading suppliers
- Estimated 2008 budget for stem cell culture products
- Percent of 2008 budget spent on stem cell media, sera, and supplements
- Estimated 2009 budget that will be dedicated to stem cell culture products
and stem cell lines
- Percent of 2009 budget that will be spent on stem cell media, sera, and
supplements
- Expected change in expenditures on stem cell media, sera, and supplements
over the next two to three years (2010 and 2011)
Stem Cell Media: Usage, Product Features and Special Requirements
- Types of media used to grow and culture stem cells
- Percent of media that is custom vs. off-the-shelf
- Estimate of stem cell culture media used per month in 2008
- Estimate of stem cell culture media expected to be used per month in 2009
- Expected change in stem cell culture media usage for two to three years
from now (2010 and 2011)
- Importance of xeno-free and animal-free types of stem cell culture media
- Advantages of stem cell culture media from primary supplier
- Satisfaction with features of stem cell culture media from primary supplier
- Requirements for GMP conditions for stem cell culture products
Stem Cells: Sources, Budgets, and Special Requirements
- General sources from which respondents acquire stem cells
- Percent of stem cell purchases made from major sources in 2008
- Percent of stem cell purchases expected to be made from major sources in
2009
- Expected changes in the percent of stem cell purchases expected to be made
from commercial suppliers over the next two to three years (2010 and 2011)
- Commercial suppliers and/or national bank/repositories from which
respondents currently purchase stem cells
- Percent of stem cell purchases made from commercial suppliers and/or
national bank/repositories
- Estimated 2008 budget for stem cell lines
- Estimated 2009 budget that will be dedicated to stem cell lines
- Reasons why respondents acquire stem cells from their primary suppliers
- Percent of stem cells grown on feeders and sources of feeder cells
- Use of 3-D cell culture in stem cell research
- Reasons for interest in 3-D cell culture for stem cell research
Supporting Products, Technologies, and Services
- Techniques respondents use to identify differentiated cell types derived
from stem cells
- Major disadvantages of techniques used to identify differentiated cell
types derived from stem cells
- Primary supplier of consumable products used to perform techniques for
identifying differentiated cell types derived from stem cells
- Stem cell-specific kits or panels currently used and planned to use in the
next 12 months
- Stages of stem cell workflow processes with which respondents are involved
- Stage of stem cell workflow that respondents would most like a new
product/technology to facilitate their research
- Types of stem cell-related services that respondents would be most
interested in obtaining from suppliers
- .
Additional Analysis by:
- Market segment
- Geographic region
- Years of experience
- Stem cell type
- Research focus
- Lab size
Section 4. Appendices
Appendix A. Respondents Planning to Conduct Stem Cell Research
- Time frame that respondents plan to begin stem cell research
- Sources of funding that will support future stem cell research
- Anticipated annual budget for stem cell culture products and stem cell
lines
- Sources and types of stem cells respondents plan to use in their research
- Differentiated cell types that will be the focus of stem cell research
- Diseases that will be the focus of stem cell research by cell type
- Sources from which respondents plan to acquire stem cells
Appendix B. Verbatim Responses to Questions
- Do you think your stem cell research will change due to the lifting of US
restrictions on federal funding for human embryonic stem cell research by the
new presidential administration? Why or why not?
- Like many stem cell pioneers, Ian Wilmut, the creator of Dolly the sheep,
has embraced an alternative approach. Are induced pluripotent stem cells the
beginning of the end for embryonic cloning? Why or why not?
|
 |
